Andere Kunden interessierten sich auch für
![Fluoroquinolone Antibiotics]( "Fluoroquinolone Antibiotics")
Fluoroquinolone Antibiotics83,99 €![Antimicrobial Drug Resistance]( "Antimicrobial Drug Resistance")
Antimicrobial Drug Resistance243,99 €![Biochemistry and Molecular Biology of Antimicrobial Drug Action]( "Biochemistry and Molecular Biology of Antimicrobial Drug Action")
Biochemistry and Molecular Biology of Antimicrobial Drug Action42,99 €![Biochemistry and Molecular Biology of Antimicrobial Drug Action]( "Biochemistry and Molecular Biology of Antimicrobial Drug Action")
Biochemistry and Molecular Biology of Antimicrobial Drug Action37,99 €![Macrolide Antibiotics]( "Macrolide Antibiotics")
Macrolide Antibiotics160,49 €![Antibiotic Discovery and Development]( "Antibiotic Discovery and Development")
Antibiotic Discovery and Development244,99 €![Antimicrobial Drug Resistance]( "Antimicrobial Drug Resistance")
Antimicrobial Drug Resistance206,99 €
Summary Antibiotics really are miracle drugs. Because of antibiotics, infectious diseases are no longer the great killer they once were, even with the advent of AIDS. In spite of this, resistance to antibiotics among disease-causing bacteria requires that we continue to discover and develop new antibiotics. A perfect storm of circumstances occurring within the pharmaceutical industry and the FDA is leading to conditions where new antibiotics will be as common as the Dodo bird leaving us all at risk.
From the reviews:
There can be few if any individuals in the world more qualified than David Shlaes to tackle the subject of antibiotics and the coming crisis posed by the twin problems of developing resistance among major human pathogens and a dwindling output of new agents with which to combat the serious infections they cause. As Dr. Shlaes clearly points out, all of this is compounded by rapid consolidation of the pharmaceutical industry and failure of regulatory agencies (especially in the United States) to provide effective oversight and guidance. Shlaes has done it all. He is a physician who knows clinical medicine, a researcher who has studied antimicrobial resistance, an administrator who has served effectively to develop new antibiotics in industry, and a consultant who understands the Food and Drug Administration from intense personal involvement. He is also a talented writer who has made this subject fascinating and understandable, even to the non-scientist! His effective use of personal vignettes and inside reporting adds to the pleasure in reading this spell-binding account. Robert C. Moellering, Jr., M.D. Shields Warren-Mallinckrodt Professor of Medical Research Harvard Medical School Department of Medicine Beth Israel Deaconess Medical Center Boston, MA USA Society is facing two converging crises: increasing antibiotic resistance and dying antibiotic development. Few understand these crises better than Dr. Shlaes, who spent years treating patients as an academic physician-scientist and then spent years in industry overseeing efforts to develop new antibiotics. In Antibiotics - The Perfect Storm, Dr. Shlaes explains how society has reached the desperate straights we are in, and describes what can be done to turn around the antibiotic crisis. His book offers a scathing, behind-the-scenes view into pharmaceutical companies and federal agencies which regulate them. Brad Spellberg Division of General InternalMedicine, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center; and David Geffen School of Medicine at UCLA
"A perfect storm describes a rare confluence of elements coming together to create a situation for the worst possible damage. ... Shales does offer very practical, realistic policy solutions for industry, researchers, the government, and society. Summing Up: Recommended. All academic audiences, from lower-level undergraduates through health care professionals/practitioners, especially those doing research and planning." (J. D. Campbell, Choice, Vol. 48 (9), May, 2011)
There can be few if any individuals in the world more qualified than David Shlaes to tackle the subject of antibiotics and the coming crisis posed by the twin problems of developing resistance among major human pathogens and a dwindling output of new agents with which to combat the serious infections they cause. As Dr. Shlaes clearly points out, all of this is compounded by rapid consolidation of the pharmaceutical industry and failure of regulatory agencies (especially in the United States) to provide effective oversight and guidance. Shlaes has done it all. He is a physician who knows clinical medicine, a researcher who has studied antimicrobial resistance, an administrator who has served effectively to develop new antibiotics in industry, and a consultant who understands the Food and Drug Administration from intense personal involvement. He is also a talented writer who has made this subject fascinating and understandable, even to the non-scientist! His effective use of personal vignettes and inside reporting adds to the pleasure in reading this spell-binding account. Robert C. Moellering, Jr., M.D. Shields Warren-Mallinckrodt Professor of Medical Research Harvard Medical School Department of Medicine Beth Israel Deaconess Medical Center Boston, MA USA Society is facing two converging crises: increasing antibiotic resistance and dying antibiotic development. Few understand these crises better than Dr. Shlaes, who spent years treating patients as an academic physician-scientist and then spent years in industry overseeing efforts to develop new antibiotics. In Antibiotics - The Perfect Storm, Dr. Shlaes explains how society has reached the desperate straights we are in, and describes what can be done to turn around the antibiotic crisis. His book offers a scathing, behind-the-scenes view into pharmaceutical companies and federal agencies which regulate them. Brad Spellberg Division of General InternalMedicine, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center; and David Geffen School of Medicine at UCLA
"A perfect storm describes a rare confluence of elements coming together to create a situation for the worst possible damage. ... Shales does offer very practical, realistic policy solutions for industry, researchers, the government, and society. Summing Up: Recommended. All academic audiences, from lower-level undergraduates through health care professionals/practitioners, especially those doing research and planning." (J. D. Campbell, Choice, Vol. 48 (9), May, 2011)